Dr Stephen M Olexo, MD | |
2000 Medical Pkwy, Suite 607, Baltimore, MD 21264-4916 | |
(410) 266-1644 | |
(410) 266-1642 |
Full Name | Dr Stephen M Olexo |
---|---|
Gender | Male |
Speciality | Critical Care (intensivists) |
Experience | 28 Years |
Location | 2000 Medical Pkwy, Baltimore, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285623116 | NPI | - | NPPES |
CL4599 110242506 | Other | MD | RR MEDICARE |
269900101 400095100 | Medicaid | MD | |
KJ86AN 61598701 | Other | MD | CAREFIRST BCBS |
S3520008 | Other | DC | CAREFIRST BCBS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0200X | Internal Medicine - Critical Care Medicine | D0058510 (Maryland) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Anne Arundel Medical Center | Annapolis, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Luminis Health Medical Group, Llc | 2860447315 | 431 |
News Archive
According a new study lack of sleep can actually contribute to mental health problems as suspected earlier. The study aimed to see if improvement in sleep could help reduce psychological problems such as paranoia and hallucinations. The study termed OASIS (Oxford Access for Students Improving Sleep) was a randomized controlled trial that involved 26 universities in the United Kingdom. The study was published in the latest issue of the journal Lancet Psychology.
Neurelis, Inc. today announced the completion of subject dosing in a randomized crossover study assessing diazepam pharmacokinetics and bioavailability after administration of two proprietary formulations of intranasal diazepam and intravenous injection.
The U.S. Food and Drug Administration (FDA) has approved the first naloxone treatment specifically designed to be given by family members or caregivers to treat a person with opioid overdose.
ChromoCure, Inc. is pleased to announce the publication of the Cervical Cancer Study, PRE-CLINICAL SYSTEM TESTING AND PERFORMANCE ASSESSMENT, conducted in conjunction with a major international Cancer Clinic. The study analyzed samples supplied by the Cancer Clinic with its Proprietary Chromosomal Scanner Technology (full text can be found @ www.ChromoCure.com/library). The study demonstrated not only the correctness of the company's cancer detection approach but also the accuracy of the scan itself. The scanner performed perfectly with flawless detection results.
FibroGen, Inc., today announced that its investigational oral anemia therapy, FG-4592, received Clinical Trial Application (CTA) approval from the Chinese State Food and Drug Administration (SFDA) to commence clinical development for the treatment of anemia associated with chronic kidney disease (CKD) in the People's Republic of China.
› Verified 5 days ago
Entity Name | Luminis Health Medical Group, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073580205 PECOS PAC ID: 2860447315 Enrollment ID: O20050317000146 |
News Archive
According a new study lack of sleep can actually contribute to mental health problems as suspected earlier. The study aimed to see if improvement in sleep could help reduce psychological problems such as paranoia and hallucinations. The study termed OASIS (Oxford Access for Students Improving Sleep) was a randomized controlled trial that involved 26 universities in the United Kingdom. The study was published in the latest issue of the journal Lancet Psychology.
Neurelis, Inc. today announced the completion of subject dosing in a randomized crossover study assessing diazepam pharmacokinetics and bioavailability after administration of two proprietary formulations of intranasal diazepam and intravenous injection.
The U.S. Food and Drug Administration (FDA) has approved the first naloxone treatment specifically designed to be given by family members or caregivers to treat a person with opioid overdose.
ChromoCure, Inc. is pleased to announce the publication of the Cervical Cancer Study, PRE-CLINICAL SYSTEM TESTING AND PERFORMANCE ASSESSMENT, conducted in conjunction with a major international Cancer Clinic. The study analyzed samples supplied by the Cancer Clinic with its Proprietary Chromosomal Scanner Technology (full text can be found @ www.ChromoCure.com/library). The study demonstrated not only the correctness of the company's cancer detection approach but also the accuracy of the scan itself. The scanner performed perfectly with flawless detection results.
FibroGen, Inc., today announced that its investigational oral anemia therapy, FG-4592, received Clinical Trial Application (CTA) approval from the Chinese State Food and Drug Administration (SFDA) to commence clinical development for the treatment of anemia associated with chronic kidney disease (CKD) in the People's Republic of China.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Stephen M Olexo, MD 2000 Medical Pkwy, Suite 607, Baltimore, MD 21264-4916 Ph: (410) 266-1644 | Dr Stephen M Olexo, MD 2000 Medical Pkwy, Suite 607, Baltimore, MD 21264-4916 Ph: (410) 266-1644 |
News Archive
According a new study lack of sleep can actually contribute to mental health problems as suspected earlier. The study aimed to see if improvement in sleep could help reduce psychological problems such as paranoia and hallucinations. The study termed OASIS (Oxford Access for Students Improving Sleep) was a randomized controlled trial that involved 26 universities in the United Kingdom. The study was published in the latest issue of the journal Lancet Psychology.
Neurelis, Inc. today announced the completion of subject dosing in a randomized crossover study assessing diazepam pharmacokinetics and bioavailability after administration of two proprietary formulations of intranasal diazepam and intravenous injection.
The U.S. Food and Drug Administration (FDA) has approved the first naloxone treatment specifically designed to be given by family members or caregivers to treat a person with opioid overdose.
ChromoCure, Inc. is pleased to announce the publication of the Cervical Cancer Study, PRE-CLINICAL SYSTEM TESTING AND PERFORMANCE ASSESSMENT, conducted in conjunction with a major international Cancer Clinic. The study analyzed samples supplied by the Cancer Clinic with its Proprietary Chromosomal Scanner Technology (full text can be found @ www.ChromoCure.com/library). The study demonstrated not only the correctness of the company's cancer detection approach but also the accuracy of the scan itself. The scanner performed perfectly with flawless detection results.
FibroGen, Inc., today announced that its investigational oral anemia therapy, FG-4592, received Clinical Trial Application (CTA) approval from the Chinese State Food and Drug Administration (SFDA) to commence clinical development for the treatment of anemia associated with chronic kidney disease (CKD) in the People's Republic of China.
› Verified 5 days ago
Dr. Leonard Anang Sowah, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-706-4619 Fax: 410-706-2062 | |
Dr. Bhavandeep Singh Bajaj, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3345 Wilkens Avenue, Suite L10, Baltimore, MD 21229 Phone: 410-644-4444 Fax: 410-644-4484 | |
Dr. Yonas Sisay, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 822 Guilford Ave, #100, Baltimore, MD 21202 Phone: 410-385-9672 | |
Dr. Stephen John Witanowski, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 2700 Quarry Lake Dr, Suite 280, Baltimore, MD 21209 Phone: 410-469-5544 Fax: 410-585-2867 | |
Dr. Susrutha Kotwal, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4940 Eastern Ave, Mfl Bldg, West Tower, 6th Floor, Baltimore, MD 21224 Phone: 410-550-5018 | |
Dr. Mitesh G Trambadia, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 6701 N Charles St Ste 5218, Baltimore, MD 21204 Phone: 443-849-3786 | |
Ronak K Patel, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 E University Pkwy, Baltimore, MD 21218 Phone: 410-554-2000 |